WELLS FARGO & COMPANY/MN - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 178 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$2,767,422
+5.5%
83,331
+0.2%
0.00%0.0%
Q3 2022$2,622,000
-71.3%
83,157
-72.4%
0.00%
-66.7%
Q2 2022$9,150,000
-14.4%
300,783
-26.9%
0.00%0.0%
Q1 2022$10,687,000
+30.9%
411,687
+2.9%
0.00%
+50.0%
Q4 2021$8,165,000
-2.7%
400,270
-8.2%
0.00%0.0%
Q3 2021$8,389,000
-16.6%
436,021
-3.9%
0.00%0.0%
Q2 2021$10,064,000
-24.9%
453,697
-11.1%
0.00%
-33.3%
Q1 2021$13,402,000
+78.9%
510,547
+27.4%
0.00%
+50.0%
Q4 2020$7,492,000
+7.0%
400,838
-2.8%
0.00%0.0%
Q3 2020$6,999,000
-27.0%
412,190
+0.2%
0.00%
-33.3%
Q2 2020$9,583,000
+126.7%
411,446
-18.2%
0.00%
+200.0%
Q1 2020$4,227,000
-44.8%
503,258
-35.8%
0.00%
-50.0%
Q4 2019$7,658,000
+41.5%
783,847
+37.5%
0.00%0.0%
Q3 2019$5,411,000
+14.3%
570,187
+43.1%
0.00%
+100.0%
Q2 2019$4,735,000
-31.6%
398,582
+1.4%
0.00%
-50.0%
Q1 2019$6,925,000
+5.7%
393,180
+4.1%
0.00%0.0%
Q4 2018$6,553,000
+16.3%
377,534
-0.2%
0.00%0.0%
Q3 2018$5,635,000
+0.7%
378,105
+7.4%
0.00%0.0%
Q2 2018$5,596,000
+8.6%
351,952
-3.0%
0.00%0.0%
Q1 2018$5,153,000
-30.2%
362,945
-31.2%
0.00%0.0%
Q4 2017$7,385,000
-18.8%
527,459
-17.1%
0.00%
-33.3%
Q3 2017$9,098,000
-15.0%
636,190
-6.4%
0.00%0.0%
Q2 2017$10,704,000
+1.0%
679,591
-11.5%
0.00%0.0%
Q1 2017$10,593,000
+17.1%
767,606
+50.2%
0.00%0.0%
Q4 2016$9,046,000
+114.2%
511,035
+133.5%
0.00%
+50.0%
Q3 2016$4,223,000
+1.1%
218,880
+2.2%
0.00%0.0%
Q2 2016$4,176,000
+5.0%
214,169
+11.0%
0.00%0.0%
Q1 2016$3,976,000
-64.5%
192,895
-64.7%
0.00%
-50.0%
Q4 2015$11,208,000
+1.1%
546,183
-15.8%
0.00%
-20.0%
Q3 2015$11,091,000
+10.5%
648,560
+20.5%
0.01%
+25.0%
Q2 2015$10,035,000
-48.5%
538,401
-47.3%
0.00%0.0%
Q1 2015$19,494,000
+235.9%
1,021,728
+189.7%
0.00%
+100.0%
Q4 2014$5,804,000
+123.6%
352,628
+140.3%
0.00%
+100.0%
Q3 2014$2,596,000
-6.5%
146,738
+9.2%
0.00%0.0%
Q2 2014$2,776,000
+14.9%
134,429
+21.3%
0.00%0.0%
Q1 2014$2,415,000
+243.0%
110,830
+317.7%
0.00%
Q4 2013$704,000
+2.2%
26,536
-9.0%
0.00%
Q3 2013$689,000
-3.8%
29,157
-12.4%
0.00%
Q2 2013$716,00033,2820.00%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q3 2018
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders